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Abstract: RNA polymerase II (Pol II) is a 12 subunit protein complex from yeast to human that is required for gene expression. Gdown1
containing Pol II [Pol II (G)] is a special form of Pol II that is catalytically inactive and heavily depends on the 30-subunit Mediator
complex for its activator and basal dependent function in vitro. Here we report for the first time, the identification and the generation
of a 15-subunit human Mediator complex via the novel multibac baculovirus expression system that is fully responsive to Pol II (G).
Our results show complete recovery of Pol II (G) dependent transcription both with full 30-subunit Mediator and also with 15-subunit
recombinant Mediator that we synthesized. Moreover, we also show that the recombinant Mediator interacts with Pol II (G) as well.
These results enlighten us towards understanding how a certain population of Pol II that is involved in selected gene regulation is
activated by Mediator complex.
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1. Introduction
Mediator complex is a multisubunit coactivator complex
consisting of different modules and is the chief regulator of
the transcription by RNA polymerase II (Pol II) (Allen and
Taatjes, 2015; Robinson et al., 2016). It was first discovered
as a purified complex in yeasts (Kim et al., 1994). Studies
have shown that Mediator complex has an essential protein
composition and structure which is largely conserved
from yeast to human (Myers and Kornberg, 2000; Malik
and Roeder, 2003). Human Mediator complex was initially
annotated as thyroid hormone receptor-associated protein
(TRAP) complex (Malik and Roeder, 2003). Subsequently,
it was found that the Mediator complex has a critical role
in not only activator dependent transcription but also
basal transcription. Furthermore, Mediator complexdepleted nuclear extracts have been shown to be defective
in terms of RNA Pol II transcription function in both
TATA promoters and TATA-less promoters (Mittler et al.,
2001; Lacombe et al., n.d.).
Human Mediator is a dynamic coactivator complex
consisting of 30 subunits with a molecular size of 2MDa
(Tsai et al., 2014). It consists of 4 modules: head, middle,
tail and kinase (Tsai et al., 2014). In humans, the head
and middle modules, together with MED14 and MED26,
constitute the active core Mediator complex (Cevher
et al., 2014). The tail and kinase modules are connected

dynamically to the core Mediator (Blazek et al., 2005). The
Mediator complex primarily transmits signals from general
transcription factors and activators to Pol II, regulating
the function of the enzyme in the preinitiation, initiation,
elongation and reinitiation stages (Yin and Wang, 2014;
Allen and Taatjes, 2015; Jeronimo and Robert, 2017).
The eukaryotic Pol II, consisting of 12 evolutionally
conserved subunits, is responsible for transcription of
all protein-encoding genes (Malik and Roeder, 2010). It
has been found that Pol II also has a 13th subunit called
Gdown1 (encoded by POL2RM), and the Pol II form
containing this subunit is called Pol II (G) (Hu et al.,
2006). Gdown1 persists to bind tightly to Pol II, even in
the presence of high concentrations of salts or urea at low
molarity. This protein is metazoan specific and is expressed
in a wide number of human tissue samples (Fagerberg et
al., 2014). Therefore, Gdown1 is thought to play important
roles in transcriptional regulation. Also, in vitro studies
have shown that the Gdown1 acts as a repressor by
inhibiting the transcription activity of Pol II in the absence
of the Mediator complex (Hu et al., 2006).
In the presence of the Mediator, however, the
inhibitory effects of Gdown1 on both activator-dependent
and -independent (basal) transcription disappear (Hu et
al., 2006; Jishage et al., 2012). Unfortunately, the biological
role of Gdown1-mediated repression and how the
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Mediator reverses this repression are not fully understood
yet. However, it was found that in the presence of Gdown1,
TFIIF’s (an important factor on PIC assembly) binding to
Pol II was inhibited, leading to a blockage of PIC assembly
(Jishage et al., 2012). Also, Gdown1 directly binds to RPB1
and RPB5 subunits of Pol II and competes with TFIIF. In
another interaction study, it has been suggested that the
region (C-terminal) where Gdown1 interacts with Pol II
coincides with TFIIF and TFIIB binding sites on Pol II
(Jishage et al., 2018). Binding of Gdown1 to Pol II inhibits
transcription by preventing TFIIF and TFIIB interaction
with Pol II in the absence of Mediator (Jishage et al.,
2018). Gdown1 also plays roles in the elongation phase
of transcription. Since Gdown1 and TFIIF interaction
sites on Pol II overlap, Gdown1 prevents the stimulation
of elongation by TFIIF and blocks termination activity of
TTF2. Phosphorylation of Gdown1 (Ser-270) by kinase
decreases the binding of Pol II and reverses the inhibition
of TTF2 and TFIIF (Cheng et al., 2012; Guo et al., 2014). As
this form of Pol II is responsive to Mediator and requires
it for function, it is critical to understand which subunits
of the Mediator are required to overcome this Gdown1
negative affect on Pol II.
In this study, in vitro transcription assays using RNA
polymerase II enzyme in the form of Pol II (G) purified
from nuclear extracts and Mediator complexes with
varying compositions (head, middle, head + middle,
head + middle + 14) produced with multibac system were
performed. Our results have shown for the first time that
both the recombinant Mediator with 15 subunits and the
full natural Mediator complex containing 30 subunits
exerted a full recovery of transcription in the presence of
Pol II (G). Moreover, we also show that this function of the
core Mediator comes from its ability to interact with Pol
II (G) that finally results in recruiting Pol II to promoters
(Cevher et al., 2014).
2. Materials and methods
2.1. Purification of Pol II (G)
HEK293 nuclear extracts were prepared from FLAGtagged Gdown1 stable cell line and dialyzed in different
concentration of TGEA buffer (with salt concentrations of
100, 150, 200 and 300 mM) and fractionated on a DE52
column. The fractionated nuclear extract (TGEA 300)
dialysate was then subjected to M2 agarose beads and
eluted with 0.5 mg/mL FLAG peptide.
The input, flow-through, and the eluates obtained
with various concentrations of the elution buffer in the
purification steps were analyzed with Western blot, in
which antibodies to Gdown1, RPB1 and RPB6 were used.
Polyacrylamide gel electrophoresis was performed to
check the purity after FLAG peptide elution and the gel
was analyzed by silver staining.
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2.1.1. Purification of activators, coactivators and general
transcription factors
General transcription factors were purified as described
before (Cevher et al., 2014). Basically, while the
recombinant TFIIB, TFIIE and TFIIE were expressed in
bacteria and purified, baculovirus expresse TFIIA as well
as the activators Gal4VP16, TRa and RXRa were purified
from insect cells and purified (Cevher et al., 2014). Full
natural Mediator, TFIID, TFIIH and Pol II were purified
from HeLa cell lines stably expressing FLAG-tagged
subunit of the corresponding protein complexes (Cevher
et al., 2014).
2.2. Reconstitution and purification of the human Mediator complex
The Head+Middle+14+26 complex was reconstituted as
described by Cevher et al. (2014). The cDNAs encoding
different Mediator subunits which were tagged with either
FLAG, Myc, 6xHis or HA tags were cloned into pFBDM
transfer vectors. Head module subunits contained pFBDM
(MED6, MED8, MED11, f-MED17, MED18, MED20,
MED22, MED30) and the middle module subunits
contained pUCDM (MED4, HA-MED7, MED9, HisMED10, Myc-MED21, MED31). The plasmids were then
integrated into the bacmid DNA and the viruses were
amplificated by transfecting Sf9 cells. After that, Hi5 cells
were infected for the production of H+M and H+M+14
complex.
Protein extraction was performed using BC500 [500
mM KCl, 20 mM Tris-Cl, pH 7.9, 20% glycerol, 0.1 mM
EDTA (pH 8.0), 0.1 mM PMSF and DTT] from Hi5
cells 60 h after infection and the lysates were washed
with BC300 [300 mM KCl, 20 mM Tris-Cl, pH 7.9, 20%
glycerol, 0.1 mM EDTA (pH 8.0), 0.1 mM PMSF and
DTT]. Subsequently, the extract was incubated with antiFLAG M2 agarose beads and the proteins were purified
by eluting with 0.5 mg/mL FLAG peptide and BC300.
Coomassie brilliant blue stain was used to confirm the
presence of proteins in the final elution.
2.3 In vitro transcription assay
Purified factor- or nuclear extract-based systems were used
in the in vitro transcription assays as described previously
(Cevher et al., 2014). For the transcription reaction, 50
ng template was used. All templates containing the G-less
cassettes downstream of the adenovirus major late (ML)
core promoter were used for transcription analysis. The
pG5ML template contained five Gal4 binding sites; the
p4TRE template contained four T3 response element
regions; p4ERED53 template contained four estrogen
response element regions and TRE3.
Purified general transcription factors (TFIIA, TFIIB,
TFIID, TFIIE, TFIIF, TFIIH) and PC4 are used for
the assay. Gal4-Vp16, T3/TR/RxR and TR/RxR were
added to the reaction mixtures containing the pG5ML,
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p4TRE and TRE3 templates, respectively, and labelled
nucleotide triphosphates either [α-32P]UTP or [α-32P]
CTP. The mixtures were incubated at 30 ºC for 50 min.
Electrophoresis was then performed and analyzed by
autoradiography.
3. Results
3.1. Reconstitution of Pol II (G) responsive form of the
Mediator complex
RNA Pol II consists of twelve evolutionarily conserved
subunits and is required for transcription of protein coding
genes. Some fraction of purified Pol II contains a tightly
associated and metazoan specific thirteenth subunit called
Gdown1 protein. This protein inhibits transcription of
Pol II in the absence of the Mediator complex. Here we
show the stepwise purification of recombinant human
Mediator complex that removes the negative effect of
Gdown1. For this, we use the novel multibac baculovirus
expression system and recombinantly generate the largest
human protein complex that has ever been reconstituted.
We basically cloned the human head module subunits

(MED17, MED18, MED22, MED11, MED30, MED20,
MED6 and MED8) and human middle module subunits
(MED31, MED21, MED10, MED31, MED7, MED4,
MED9) along with MED14 into pFBDM and pUCDM
transfer vectors (Figure 1a). Later, we verified the cloned
subunits within these plasmids by PCR (Figure 1b). Upon
verification of the cloned subunits, we transformed them
in to DH10Multibac containing bacteria. We later purified
the DH10 Multibac bacmid from bacteria, verified
that the transfer vectors integrated in to the bacmid via
transposition as well as Cre-lox P recombination and then
transfected insect Sf9 cells with the purified bacmid (Figure
1c). Finally, we extracted proteins from insect cells and
purified our recombinant Mediator proteins via affinity
purification (against FLAG tag) followed by Superose 6 gel
filtration (size exclusion chromatography) to get pure and
near homogenous proteins (Figure 1d).
3.2. Reconstitution of Pol II (G) form of the polymerase
from HEK293 cell extracts
Hek293 cell extracts were stably expressed with f:Gdown1
protein in order to saturate Pol II with Gdown1 and purify

Figure 1. Reconstitution of Pol II (G) responsive form of the human Mediator. (a) Recombinant human head module subunits (MED17,
MED8, MED20, MED30, MED11, MED22, MED6 and MED18) and human middle module subunits (MED7, MED21, MED31,
MED10, MED4, MED26 and MED9) and the linker MED14 were cloned into pFBDM and pUCDM transfer vectors respectively. (b)
PCR product of human Mediator head and middle module subunits cloned in to pFBDM and pUCDM transfer plasmids. (c) The
transfer plasmids bearing the head and middle module subunits were transformed into DH10 Multibac containing bacteria. Bacmid
was isolated from DH10 Multibac bacteria and transfected to Sf9 insect cells. (d) Protein lysates were prepared and incubated with M2
agarose beads. M2 agarose bound proteins were washed and eluted with FLAG peptide and ran on Superose 6 gel filtration column for
further purification. Finally, purified proteins were visualized by coomassie (CS) or silver stain (SS).
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large quantity of Pol II with saturated Gdown1. As the tag
is on Gdown1, purification of Pol II via FLAG tag ensures
that 100% of purified Pol II contains Gdown1 protein.
The cell extract was prepared and dialyzed against TGEA
with 100 mM salt. Later, the sample was loaded to DE52
anion exchange column (Figures 2a and 2b). The bound
proteins were eluted and the fraction with 300 mM TGEA
was collected and put to M2 agarose for FLAG tag affinity
purification. The purified protein was then resolved in
SDS page and silver stain showing all subunits of Pol II
along with Gdown1 was observed (Figure 2c).
3.3. In vitro transcription with recombinant Mediator
Prior to checking the activity of our recombinant Mediator
with Pol II (G), we characterized its function with HeLa
nuclear extracts where the source of transcription comes
from HeLa extracts. Basically, we immunodepleted
Mediator from HeLa nuclear extracts and performed
in vitro transcription reactions by supplementing the
Mediator depleted nuclear extracts with our recombinant
Mediator complexes. As the nuclear extract has a
population of Pol II and Pol II (G), we did in vitro
transcription with nuclear extracts and characterized if
our recombinant Mediators could recover transcription.
As can be seen in Figure 3a, neither head, nor middle

nor head+middle could recover transcription (lanes
1–8). However, our human core Mediator complex could
recover transcription to its full potential (lane 9). Later, we
checked if the transcription was dose dependent on the
recombinant human core Mediator complex and saw that as
we increased the concentration of this protein complex, we
observed more and more transcripts (Figure 3b). Finally,
we checked if our recombinant Mediator could recover
activated transcription with VP16. For this, we used the
natural 30-subunit Mediator complex as a positive control
as it fully responds to VP16. As VP16 does not interact
with the core-Mediator complex, we expected not to see an
activated recovery of transcription but basal transcription
(Figure 3c, compare lanes 3–4 to lanes 7–8). This way we
verified that our recombinant Mediator is fully functional.
3.4. In vitro transcription with activators TR/RXR
nuclear extracts and purified system with Pol II (G)
Human Mediator was initially purified from liganded
thyroid hormone receptor (TR/RXR). As Mediator
strongly interacts with this activator and fully responds in
transcription, we recombinantly generated and purified
thyroid hormone receptor and its partner retinoid X
receptor (Figure 4a). We next tested if this liganded
activator responds to Mediator dependent transcription

Figure 2. Purification of Pol II (G) from HEK293 cells stably expressing f:Gdown1. (a) Cell extracts were made from HEK293 Cells
stably expressing FLAG-tagged Gdown1 protein. The extract was initially dialyzed to 100 mM TGEA and loaded to DE52 ion exchange
resin. Bound proteins were eluted with 100 mM, 150 mM, 200 mM and 300 mM TGEA buffer. (b) Western blot showing each elution
step of Pol II (G) containing cell extract with TGEA. (C) The 300 mM TGEA fraction was collected and incubated with M2 agarose
beads. Later M2 agarose bound proteins were eluted with FLAG peptide and resolved in SDS page gel.
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Figure 3. Pol II (G) responsive recombinant human Mediator was tested for transcription with HeLa nuclear
extracts bearing Pol II (G). (a) HeLa nuclear extracts were depleted from Mediator with beads crosslinked with
MED30 antibody. This antibody can remove the entire 30-subunit Mediator from nuclear extracts. Recombinant
Mediator modules (head, middle, head-middle and core [head-middle and MED14)] were supplemented to
Mediator depleted HeLa nuclear extracts in order to observe recovery of transcription. (b) HeLa nuclear extracts
depleted with Mediator was supplemented with increasing concentration of recombinant human core-Mediator
complex from (a) that fully responded to transcription. (c) In vitro transcription was done as in (a) except this
time activator Gal4VP16 was supplemented to in vitro transcription reactions.

in the presence (Figure 4b, lanes 1–10) and absence of
Mediator (Figure 4b, lanes 11–20). For that we used either
Mediator depleted or not depleted nuclear extracts. As can

be seen, the activator TR/RXR (lanes 3 vs. 7) and VP16
(lanes 9 vs. 10) fully responded to Mediator dependent
transcription. Once we optimized the working conditions
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for Mediator and the activator in nuclear extracts that
partially has Pol II (G), we next purified all the general
transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF
and TFIIH), PC4, Mediator and Pol II (G) and optimized
transcription with varying amounts of Pol II (G) in the
presence and absence of Mediator and TR/RXR (Figure
4c). With the Mediator, the negative effect of Gdown1 was
fully recovered for both basal (lanes 1 vs. 3 and 5 vs. 7) and
activated transcription (lanes 2 vs. 4 and 6 vs. 8).
3.5. Recombinant human core Mediator complex removes Gdown1 negative effect on Pol II and associates
with Pol II (G)
Finally, we wanted to characterize if our recombinant
human core Mediator complex could revert the negative
effect of Gdown1 on Pol II. In order to do these kinds of
experiments, our lab is equipped with unique recombinant
purified system where we can dissect in to purified proteins
(general transcription factors) to understand the necessity/
function of each factor in the in vitro transcription system.
Therefore, we purified all GTFs (Cevher et al., 2014), PC4

and recombinant Mediator variants among with Pol II (G)
(Figure 2) and tested if the recombinant Mediator could
revert the negative effect of Gdown1 on Pol II just like a
full natural 30-subunit Mediator can. Remarkably, for the
first time, we can see from Figure 5a that the recombinant
human core Mediator could recover basal transcription
of Pol II (G) to the same extent as full natural 30-subunit
Mediator. This suggests us that the subunits within this
16 subunit core Mediator could revert the negative effect
of Gdown1 and may not need the tail and the kinase
modules to overcome this effect. Next, we checked if the
recombinant human core Mediator could recover TR/
RXR activated transcription. Here, as we know that our
human core Mediator does not interact with TR/RXR,
we do not expect it to recover activated transcription
but we expect it to only recover basal transcription. As
can be seen from Figure 5b, while the natural Mediator
could recover both activated and basal transcription (lanes
1–4), the recombinant core Mediator could only recover
basal transcription (lanes 5–8) proving once again that
our human core Mediator fully responds to Pol II (G) and

Figure 4. Purification of TR/RXR, in vitro transcription with TR/RXR and TR/RXR-Pol II (G). (a) Western blot of purified FLAGtagged thyroid hormone receptor and retinoid X receptor. (b) In order to validate function for TR/RXR and the purified Mediator
complex and to set-up a functional transcription assay, in vitro transcription assay was conducted on Gal4-VP16 responsive pG5HML
and TR responsive 3TRE templates. Lanes 1–10 were performed with Mediator depleted extracts while lanes 11–20 were conducted with
mock (control) treated NE. Supplementation of purified Mediator and activators fully recovered and enhanced transcription. (c) In vitro
transcription was conducted as in (b) this time with purified general transcription factors (GTF) and purified Pol II (G) to validate their
activity. Basically, purified GTFs (TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH), purified Pol II (G) and Mediator was used along with
the activators TR and RXR to test the activity of Pol II (G).
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removes the negative effect. Mediator exerts its function
mainly by binding to RNA Pol II and recruiting it to
promoters. Finally, in order to understand the mechanism
of how the recombinant human core Mediator activates Pol
II (G) transcript, we checked if this recombinant Mediator

could interact with Pol II (G). Remarkably, for the first
time, we see that this form of the Mediator interacts to its
full extent with Pol II (G) (Figure 5c, lanes 4 vs. 5) and
telling us this is how it can recruit this form of Pol II to
promoters (Figure 6).

Figure 5. Functional and mechanistic characterization of Pol II (G) responsive form of recombinant Mediator. (a) Purified GTF’s
were used here along with recombinant core and endogenous purified full length Mediator complex to test the recovery of Gdown1
negative effect on Pol II. Natural Mediator (lanes 1–2), PC2 Mediator (kinase module lacking form of endogenous Mediator, lane 2)
and recombinant core Mediator complex (lanes 4–5) was tested for recovery of basal level transcription done with Pol II (G) (lanes
4–5). Gdown1 free Pol II was used as a control to show activity of recombinant Mediator and the negative effect of Gdown1 (lanes 6–7).
(b) In vitro transcription was done as in (a). This time TR/RXR was used to observe activated transcription in the presence of either
natural Mediator (lanes 1–4) and recombinant core Mediator (lanes 5–8). (c) Core Mediator association with Pol II (G) was tested via
immunoprecipitation. Head+14 served as a negative control.
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Figure 6. Model showing the recovery of transcription done with human core Mediator
complex and Pol II (G).
In the presence of the human core Mediator complex composing of Mediator head
(MED6, MED8, MED11, MED17, MED18, MED20, MEDD22 and MED30), middle
(MED4, MED7, MED10, MED21, MED26 and MED31) modules and the linker subunit
between the two modules (MED14), Mediator can bind to Pol II (G) and facilitate
transcription by removing Pol II (G)’s Gdown1 negative effect on transcription. This
removal of negative effect of Gdown1 by the core Mediator complex is comparable to
the natural Mediator.

4. Discussion
Mediator complex is critical for both basal and activated
transcription as it serves as a hub between enhancer bound
activators and promoter bound general transcription
factors. In fact, Mediator was first isolated in yeast with Pol
II and thus was called a holoenzyme. Its strong association
with Pol II is a key property of Mediator as it brings Pol
II to promoters to facilitate transcription (Cevher et al.,
2014). Later, Mediator was purified from human cell
extracts through liganded thyroid hormone receptor
and hence was initially named as thyroid hormone
receptor-associated protein complex (TRAP). Later, we
recombinantly generated the core-Mediator complex
composing of head+middle+MED14 to bind to Pol II and
recruit Pol II to promoters to facilitate transcription. A long
standing question was in what is the Mediator component
that could revert the negative effect of Gdown1 protein in
Pol II (G). Previously, we reconstituted the largest protein
complex up to date and showed that the recombinant
human Mediator can fully activate Pol II mediated
transcription (Cevher et al., 2014). Here, in order to see if
our recombinant core could recover transcription of Pol II
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(G) and compare it to the full natural Mediator complex,
we tested our recombinant human core-Mediator complex
for in vitro transcription and coimmunoprecipitation
assays. Remarkably, our in vitro transcription assays as
well as coimmunoprecipitation show that the recombinant
Mediator not only can bind to Pol II (G) but also can
revert its negative effect on transcription just like the
natural Mediator can. Our findings now open-up new
avenues towards understanding the Mediators role at
its subunit, modular and multimodular level in detailed
understanding of not only how enhancer bound activated
genes are activated (Cevher et al., 2014) but also how the
negative effects are overcome by the Mediator complex.
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